NorthRock Partners LLC decreased its stake in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 9.5% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,203 shares of the medical device company’s stock after selling 335 shares during the quarter. NorthRock Partners […]
Shares of DexCom, Inc. (NASDAQ:DXCM – Get Free Report) have received a consensus rating of “Moderate Buy” from the sixteen analysts that are presently covering the firm, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation, thirteen have given a buy recommendation and one has issued a strong buy recommendation […]
Retirement Systems of Alabama trimmed its holdings in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 22.9% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 88,101 shares of the medical device company’s stock after selling 26,111 shares during the quarter. Retirement […]
DexCom (NASDAQ:DXCM – Free Report) had its price objective decreased by JPMorgan Chase & Co. from $160.00 to $100.00 in a report issued on Tuesday morning, Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the medical device company’s stock. Several other equities research analysts have also issued reports on the company. […]
Leerink Partnrs restated their outperform rating on shares of DexCom (NASDAQ:DXCM – Free Report) in a research report sent to investors on Monday, PriceTargets.com reports. Leerink Partnrs also issued estimates for DexCom’s Q3 2023 earnings at $0.37 EPS, Q4 2023 earnings at $0.42 EPS, Q1 2024 earnings at $0.30 EPS, Q2 2024 earnings at $0.39 […]